These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 15337261
21. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K. Neurosci Lett; 2008 Aug 01; 440(2):145-9. PubMed ID: 18555606 [Abstract] [Full Text] [Related]
22. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease. Ahn Jo S, Ahn K, Kim JH, Kang BH, Kim E, Jo I, Kim DK. Clin Chim Acta; 2006 Jun 01; 368(1-2):179-82. PubMed ID: 16480703 [Abstract] [Full Text] [Related]
26. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4. Kim KW, Suh YJ, Park WY, Jhoo JH, Lee DY, Youn JC, Lee KH, Seo JS, Woo JI. Neurosci Lett; 2004 Aug 12; 366(2):182-6. PubMed ID: 15276243 [Abstract] [Full Text] [Related]
28. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Bullido MJ, Artiga MJ, Recuero M, Sastre I, García MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vázquez J, Goate A, Valdivieso F. Nat Genet; 1998 Jan 12; 18(1):69-71. PubMed ID: 9425904 [Abstract] [Full Text] [Related]
29. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Köppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H. Clin Cancer Res; 2004 May 15; 10(10):3518-20. PubMed ID: 15161710 [Abstract] [Full Text] [Related]
30. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease. Licastro F, Veglia F, Chiappelli M, Grimaldi LM, Masliah E. Neurobiol Aging; 2004 Sep 15; 25(8):1017-22. PubMed ID: 15212826 [Abstract] [Full Text] [Related]
31. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity. Nacmias B, Bagnoli S, Tedde A, Cellini E, Bessi V, Guarnieri B, Ortensi L, Piacentini S, Bracco L, Sorbi S. Arch Gerontol Geriatr; 2007 Sep 15; 45(2):201-6. PubMed ID: 17182125 [Abstract] [Full Text] [Related]
32. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, Tian Y. Brain Res; 2009 Feb 09; 1253():169-75. PubMed ID: 19073159 [Abstract] [Full Text] [Related]
38. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. Mirowska-Guzel D, Gromadzka G, Czlonkowski A, Czlonkowska A. J Neuroimmunol; 2009 Sep 29; 214(1-2):113-7. PubMed ID: 19628284 [Abstract] [Full Text] [Related]
39. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A, ITINAD Working Group. Neurobiol Aging; 2009 Sep 29; 30(9):1406-12. PubMed ID: 18179845 [Abstract] [Full Text] [Related]
40. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Mol Psychiatry; 2002 Sep 29; 7(8):886-90. PubMed ID: 12232782 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]